Datametrex AI Ltd V.DM

Trust the numbers...

[wildbird1]

In Q1,2021 on $19 million revenues, the increase in cash in the Bank was +$2.6 million(over year end 2020).

Logic would have it that if Q2 tests revenue are less than Q1 tests revenue($19 million), the increase in cash in the Bank would have been less than the Q1 +$2.6 million increase.

On the contrary according to M.Gunter cash in the Bank has increased to $13 million, an increase of +$8.4 million.
An increase of 200% in cash in the Bank over Q1,2021 can't happen if revenues did not increase big time.

We are definitively missing some numbers.

My guess....
The press release do not mention Datametrex New Rapid Antigen tests revenues(only PCR tests are mentioned).
In the Deep Dive video(April 6,2021), M.Gunter said" We have already brought in several purchase orders on these Rapid Antigen Tests.

Trust the numbers...
Cash in the Bank can't increase by 200%($4.6 to $13 million) if revenue did not increase.

[MUTDMUTD]

... Astutein, any comment or response to my friend wildbird's quite well presented statement? Thanks wildbird, great analysis and presentation!

[themason]

Wildbird, it's great that they have cash in the bank but the market is not interested in cash from covid, they want to know if they are making money from Ai, just take a looksy at SCRN, no interest in covid stocks

[MomenTom]

Thats's probably because of the receivables.  When you sell, you get paid later, let's say 30 to 90 days.  They had 9 millions in March 2021 in receivables... so when that got paid, the cash went from 3 to 12 millions.  Meanwhile, more recent testing increased receivables and they'll get paid later for that and so on.  (oversimplified)  So based on that, we can

[shaker13]

Excellent summation No denying the numbers